C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/48 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01)
Patent
CA 2398887
Pyrimidine derivatives of formula (I) wherein Q1, Q2, G and R1 are as defined within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described.
L'invention concerne des dérivés pyrimidine représentés par la formule (I) dans laquelle Q1, Q2, G et R<1> sont tels que définis dans les spécifications; et des sels pharmaceutiquement acceptables et des esters de ceux-ci hydrolysables <i>in vivo</i>. L'invention concerne les procédés de préparation desdits dérivés, des compositions pharmaceutiques et leur utilisation comme sérine/thrénine kinase (CDK) dépendant de la cycline, et comme inhibiteurs de kinase d'adhésion focale (FAK).
Bradbury Robert Hugh
Pearson Stuart Eric
Pease Elizabeth Janet
Williams Emma Jane
Astrazeneca Ab
Smart & Biggar
LandOfFree
2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1418160